125 related articles for article (PubMed ID: 36122619)
21. Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
Pfefferkorn M; Böhm S; Schott T; Deichsel D; Bremer CM; Schröder K; Gerlich WH; Glebe D; Berg T; van Bömmel F
Gut; 2018 Nov; 67(11):2045-2053. PubMed ID: 28951526
[TBL] [Abstract][Full Text] [Related]
22. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.
Hildt E; Hofschneider PH
Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012
[TBL] [Abstract][Full Text] [Related]
23. Association of the Hepatitis B Virus Large Surface Protein with Viral Infectivity and Endoplasmic Reticulum Stress-mediated Liver Carcinogenesis.
Lin WL; Hung JH; Huang W
Cells; 2020 Sep; 9(9):. PubMed ID: 32911838
[TBL] [Abstract][Full Text] [Related]
24. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus surface gene pre-S
Yen CJ; Ai YL; Tsai HW; Chan SH; Yen CS; Cheng KH; Lee YP; Kao CW; Wang YC; Chen YL; Lin CH; Liu T; Tsai HP; Wang JR; Su IJ; Huang W
Hepatology; 2018 Sep; 68(3):815-826. PubMed ID: 29350774
[TBL] [Abstract][Full Text] [Related]
26. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C
Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684
[TBL] [Abstract][Full Text] [Related]
27. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
[TBL] [Abstract][Full Text] [Related]
28. Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B.
Pfefferkorn M; Schott T; Böhm S; Deichsel D; Felkel C; Gerlich WH; Glebe D; Wat C; Pavlovic V; Heyne R; Berg T; van Bömmel F
J Hepatol; 2021 Feb; 74(2):283-292. PubMed ID: 32931877
[TBL] [Abstract][Full Text] [Related]
29. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.
Mun HS; Lee SA; Kim H; Hwang ES; Kook YH; Kim BJ
J Virol; 2011 Jan; 85(1):123-32. PubMed ID: 20962085
[TBL] [Abstract][Full Text] [Related]
30. The Serum Hepatitis B Virus Large Surface Protein as High-Risk Recurrence Biomarker for Hepatoma after Curative Surgery.
Tsai HW; Lee YP; Yen CJ; Cheng KH; Huang CJ; Huang W
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628188
[TBL] [Abstract][Full Text] [Related]
31. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection.
Liu Y; Maiers JL; Rui Y; Jiang X; Guleng B; Ren J
Int J Biochem Cell Biol; 2021 Feb; 131():105906. PubMed ID: 33370716
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
[TBL] [Abstract][Full Text] [Related]
36. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma and hepatitis B surface protein.
Li YW; Yang FC; Lu HQ; Zhang JS
World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
[TBL] [Abstract][Full Text] [Related]
39. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations.
Geissler M; Bruss V; Michalak S; Hockenjos B; Ortmann D; Offensperger WB; Wands JR; Blum HE
J Virol; 1999 May; 73(5):4284-92. PubMed ID: 10196326
[TBL] [Abstract][Full Text] [Related]
40. Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus Production.
Inoue J; Ninomiya M; Umetsu T; Nakamura T; Kogure T; Kakazu E; Iwata T; Takai S; Sano A; Fukuda M; Watashi K; Isogawa M; Tanaka Y; Shimosegawa T; McNiven MA; Masamune A
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
